Hey sb, thank you for your reply, also respect your profession.
Am a little unclear on the answers to my questions, in regards to why the slow take off with the CardioCel and whether the medical profession/surgeons are slow in accepting new tech.
That CardioCel has been around for 8 or so years I would have thought that it would have gone 'gang busters' by now. I have a client (humble garden maintenance business!) who had a heart procedure not that long ago, he mentioned the ' bovine' word. Asked him who and it was: Edwards Lifesciences, the product was C- E Perimount Magna.
Did a post ages ago on why wouldn't this product (CardioCel)be approved for the betterment of patients, two comments that I remember. One: Business and ethics are like oil and water, two: you could get special permission to use.
Apologies in advance if I have got something wrong, just a layman wondering why the tech and IP of this company sp is so low, despite CR s and a share consolidation.
"Take a Closer Look", page-669
-
- There are more pages in this discussion • 559 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $294.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |